Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Sensitisation data (human)

Currently viewing:

Administrative data

Endpoint:
sensitisation data (humans)
Type of information:
other: Medicak data/ clincal observations
Adequacy of study:
supporting study
Study period:
1981
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
test procedure in accordance with national standard methods with acceptable restrictions

Data source

Reference
Reference Type:
publication
Title:
Unnamed
Year:
1981

Materials and methods

Type of sensitisation studied:
skin
Study type:
case report
Test guideline
Qualifier:
no guideline required
Principles of method if other than guideline:
For details on principles of method see below.
GLP compliance:
not specified

Test material

Constituent 1
Chemical structure
Reference substance name:
Cyanamide
EC Number:
206-992-3
EC Name:
Cyanamide
Cas Number:
420-04-2
Molecular formula:
CH2N2
IUPAC Name:
cyanamide
Details on test material:
- Name of the test substance: Cyanamide (Colme: hydrogen cyanamide)

Method

Type of population:
occupational
Ethical approval:
not applicable
Subjects:
Workers in a psychiatric ward assistanting in handling numerous medicines (mostly in the form of capsules and pills and sometimes as solutions like Colme)
Route of administration:
dermal

Results and discussion

Results of examinations:
Specific tests were performed with the medicines he normally handled; he gave a +++ positive reaction to Colme at 10 and 50 %. The reactions were still visible after 30 days as a bluish-black coloration. Thirty controls were negative. Colme contains 6 g per 100 mL of cyanamide in a stabilising vehicle of sorbic acid, sedium acetate and distilled water. Patch tests with the substances showed positive reactions only to cyanamide at 0.1, 0.5, 1 and 5 % in water at 48 and 96 h. All control tests were negative. The worker henceforth avoided all contact with Colme and his dermatitis resolved completely.

Any other information on results incl. tables

No remarks

Applicant's summary and conclusion

Conclusions:
An allergic contact dermatitis to cyanamide (carbodiimide)
Executive summary:

A 32-year old man had been working for a year and a half in a psychiatric ward as an assistant handling numerous medicines, mostly in the form of capsules and pills and sometimes as solutions. Four months ago, the pulps of his thumb, index and middle fingers on the right hand, showed an erythemato-squamous dermatitis which was very itchy and later developed fissuring. He did not respond to topical applications and antihistamines. He noted, however, that the dermatitis sometimes improved spontaneously when he was away from work. During a normal working day he was in direct contact with about 40 medicines, such as tranquillisers, neuroleptics, vitamins, antialcoholic drugs, etc. Specific tests were performed with the medicines he normally handled; he gave a +++ positive reaction to Colme at 10 and 50 %. The reactions were still visible after 30 days as a bluish-black coloration. Thirty controls were negative. Colme contains 6 g per 100 mL of cyanamide in a stabilising vehicle of sorbic acid, sedium acetate and distilled water. Patch tests with the substances showed positive reactions only to cyanamide at 0.1, 0.5, 1 and 5 % in water at 48 and 96 h. All control tests were negative. The patient henceforth avoided all contact with Colme and his dermatitis resolved completely.